Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00153894 · ClinicalTrials.gov registry record · NA
Effects of Exercise Intervention on Insulin Levels in Breast Cancer Survivors
A NA study, sponsored by Dana-Farber Cancer Institute.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT00153894 is a NA study that has completed, run by Dana-Farber Cancer Institute. The registered enrollment target is 100 participants.
The verdict
NCT00153894, a NA study, has completed, sponsored by Dana-Farber Cancer Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether an exercise program comprised of strength and endurance training will lower fasting insulin levels in a group of breast cancer survivors. Insulin may be involved in the risk of breast cancer recurrence.
Interventions
- BEHAVIORAL Strength training
- BEHAVIORAL Endurance training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2003-12 |
| Est. Completion | 2008-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00153894
The ClinicalTrials.gov registry entry for NCT00153894 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dana-Farber Cancer Institute, which has 781 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Strength training is the first listed.
NCT00153894 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00153894 about?
NCT00153894 is a clinical study titled "Effects of Exercise Intervention on Insulin Levels in Breast Cancer Survivors". The purpose of this study is to determine whether an exercise program comprised of strength and endurance training will lower fasting insulin levels in a group of breast cancer survivors. Insulin may be involved in the risk of breast cancer recurrence.
What is the current status of trial NCT00153894?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2003-12. Estimated completion is 2008-02.
What interventions are being tested in trial NCT00153894?
The interventions under investigation include: Strength training (BEHAVIORAL), Endurance training (BEHAVIORAL).
Who is sponsoring clinical trial NCT00153894?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.